Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more

White Paper: Challenges of HTA and Reimbursement Submissions for Medical Devices

Get insights from MTRC White Papers to explore the complexities of reimbursement and HTA submissions for medical devices in Europe and discover practical solutions to overcome these challenges

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Health Technology Assessment and Cardiology: A Review of the Present and Future of Innovation

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. 

In a recent publication, Casado-Arroyo et al. assessed the current landscape of health technology assessment (HTA) for innovative cardiology devices in Europe. The review identified three central themes: the expanding role of clinicians in HTA processes, the integration of digital technologies and AI into assessment frameworks, and significant variation in HTA practices across EU countries. The authors noted that new regulatory initiatives, such as the HTA Regulation, could facilitate alignment between clinical practice, evidence-based evaluation, and reimbursement processes.

Access the full-text article here.